Carolyn Chamberlain


With a track record of more than 20+ years of experience in pharmaceutical market research, both client and agency side, working in a variety of roles, Carolyn brings substantial knowledge, enthusiasm and experience to actively achieve results.

Carolyn is a well-known strategic market leader in qualitative and quantitative insight in both the UK and overseas. She is passionate about engaging with a diverse range of stakeholders and driving debate in our industry.

Her career began at AstraZeneca Global where she led insights teams within CV and Oncology for over a decade. Her contributions helped drive the growth of blockbusters such as Crestor, Zoladex, Arimidex and Faslodex. 

Over the last 15 years, she has held senior commercial and leadership positions with IPSOS, Kantar Health and the Adelphi Group, whilst also being a key contributor to EphMRA, PMRC and the BHBIA.

Carolyn has extensive experience in both selling, developing and leading all parts of the project lifecyle.